NAGPA
Chr 16N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
Also known as: APAA, UCE
This enzyme catalyzes the second step in forming mannose 6-phosphate targeting signals on lysosomal enzymes by removing N-acetylglucosamine residues from specific sugar moieties. Mutations cause developmental stuttering, with inheritance pattern not clearly established from available data. The gene shows minimal constraint against loss-of-function variants (pLI near zero, LOEUF 1.32), suggesting tolerance to reduced gene dosage.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Tolerant to missense variation
ClinVar Variant Classifications
100 submitted variants in ClinVar
Classification Summary
Curated Variants Distribution
Classified variants from ClinVar · 5 ACMG categories
| Classification | LoF | Missense + Inframe | Non-coding | Synonymous | Total |
|---|---|---|---|---|---|
Pathogenic | 0 | 0 | 2 | 0 | 2 |
Likely Pathogenic | 0 | 0 | 0 | 0 | 0 |
VUS | 0 | 67 | 2 | 0 | 69 |
Likely Benign | 0 | 1 | 0 | 0 | 1 |
Benign | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 68 | 4 | 0 | 72 |
LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly
View in ClinVar →Protein Context — Lollipop Plot
NAGPA · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
3D Protein StructureAlphaFold
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →External Resources
Links to major genomics databases and tools